GGrantIndex
Sort

64,565 grants matching drug discovery

Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU

$1,433,652
Vladislav Bergo · Adeptrix Corporation · R44 · FY2023 · AG

Malaria Drug Resistance and Disease Virulence

$1,433,451
Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Oncogenic Kinases in Cancer

$1,433,387
John Brognard · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders

$1,433,100
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Split-Maze Discovery of Antiobesity Drugs

$1,432,975
Novasite Pharmaceuticals, Inc. · R44 · FY2002 · DK

Modulation of Therapeutic Response

$1,432,969
James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae

$1,432,109
Zachary David Aron · Microbiotix, Inc · R01 · FY2017 · AI

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center

$1,431,641
Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2025 · CA

Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder

$1,431,556
Yan Zhang · Virginia Commonwealth University · UH3 · FY2023 · DA

MSKCC Center for Molecular Imaging in Cancer

$1,431,511
Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2012 · CA

Studies of Hereditary Neurological Disease: Disease Mechanisms

$1,431,477
Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS

Development of small-molecule autophagy modulators

$1,430,563
Leslie Aldrich · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Discovery of cGAS-like signaling enzymes in innate immunity and disease

$1,430,400
Philip J Kranzusch · Dana-Farber Cancer Inst · DP2 · FY2021 · GM

Targeting Eph receptors in cancer

$1,430,343
Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2014 · CA

Pre-Clinical Testing Core

$1,430,214
Paul Richard Territo · Indiana University Indianapolis · U54 · FY2020 · AG

Application of progenitor niche signals to ex vivo nephrogenesis

$1,430,072
Leif Oxburgh · Mainehealth · R24 · FY2015 · DK

Development of drugs that target the M2 proton channel from the influenza A Virus

$1,430,000
William F Degrado · University Of Pennsylvania · U01 · FY2008 · AI

Genetic Basis Of Cortical Malfunction In Schizophrenia

$1,429,547
Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2013 · MH

Pharmacology Core

$1,428,749
Vidmantas Petraitis · Hackensack University Medical Center · U19 · FY2025 · AI

Molecular Correlates Of Human Ca2+ Channel Regulation

$1,428,517
Nikolai Soldatov · National Institute On Aging · ZIA · FY2009 · AG

Emory Winship Cancer Institute Cancer Center Support Grant

$1,428,397
Walter John Curran · Emory University · P30 · FY2010 · CA

Emory Winship Cancer Institute Cancer Center Support Grant

$1,428,397
Walter John Curran · Emory University · P30 · FY2009 · CA

Non-Metabolized Pregnenolone Derivatives:New Treatment for Cannabis Use Disorder

$1,427,946
Margaret Haney · Columbia University Health Sciences · R01 · FY2017 · DA

Developmental Mechanisms of Human Idiopathic Scoliosis

$1,427,879
Carol A Wise · Ut Southwestern Medical Center · P01 · FY2022 · HD

Improving precision health approaches through large-scale EHRs and biobanks

$1,427,000
Joshua Denny · National Human Genome Research Institute · ZIA · FY2024 · HG